The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001177347
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/09/2026
Date registered
Help: Date registered
22/09/2026
Date last updated
Help: Date last updated
3/11/2026
Date data sharing statement initially provided
Help: Data sharing statement date
22/09/2026
Date results provided
Help: Date results provided
3/11/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Does listening to a daily guided meditation audio track reduce pain and anxiety in hip or knee replacement surgery patients? A randomised controlled trial.
Scientific title
The effect of a brief guided meditation intervention on postoperative pain severity, pain interference, and anxiety compared with placebo audio and treatment as usual in adults undergoing total joint arthroplasty: a three-arm, double-blind, randomised controlled trial.
Additional trial identifiers [1] 318276 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Acute postoperative pain 343378 0
Anxiety 343379 0
Condition category
Condition code
Mental Health 339467 339467 0 0
Anxiety
Anaesthesiology 339468 339468 0 0
Pain management
Alternative and Complementary Medicine 339469 339469 0 0
Other alternative and complementary medicine

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm 1 (Guided meditation): A 40-minute audio guided meditation track (provided by iAwake Technologies, LLC) comprising a natural soundscape (flowing water, wind, rain) modulated with neural entrainment methods, including binaural beats (174 Hz carrier frequency), isochronic pulses, monaural beats, amplitude modulation, exhaustive spatial binaural encoding, and rhythmic panning. Participants self-administered the track at home once daily via their own listening device and headphones, commencing on postoperative Day 1 or as soon as practicable thereafter, for 14 consecutive days. Adherence was self-recorded on a daily one-page log, which also recorded daily analgesic medication use, and was returned to the research team at the end of the intervention period. Participants received a single 40-minute track and administered the same track each day for the 14-day period. Participants were instructed to sit or lie still with their eyes closed for the duration of the 40-minute track, wearing headphones, at a time of their choosing each day.

Arm 2 (Placebo audio): A 40-minute placebo audio track identical in audible content to the active track (same natural soundscape) but containing no neural entrainment technology, delivered under the identical schedule and procedures as Arm 1. Active and placebo tracks were supplied to the research team as identical files distinguishable only by a random 6-digit code, with file identities withheld by the developer until study completion.
Intervention code [1] 335261 0
Treatment: Other
Description of the comparator or control
Two comparators. (1) Placebo audio: a 40-minute placebo audio track identical in audible content to the active track (same natural soundscape of flowing water, wind, and rain) but containing no neural entrainment technology, self-administered under the identical schedule and instructions as Arm 1 (once daily for 14 consecutive days commencing postoperative Day 1 or as soon as practicable, sitting or lying still with eyes closed and wearing headphones), with adherence and analgesic use recorded on the same daily log. Active and placebo tracks were supplied as identical files distinguishable only by a random 6-digit code, with identities withheld by the developer until study completion. (2) Treatment as usual (TAU): standard postoperative care with no audio intervention; TAU participants completed the daily medication log only.
Control group
Placebo

Outcomes
Primary outcome [1] 346788 0
Pain interference, assessed as the mean of the seven BPI interference items.
Timepoint [1] 346788 0
Baseline (pre-treatment) and 14 days after intervention commencement (primary timepoint).
Primary outcome [2] 346895 0
Pain severity
Timepoint [2] 346895 0
Baseline (pre-treatment) and 14 days after intervention commencement (primary timepoint).
Secondary outcome [1] 467522 0
Generalised anxiety symptoms at extended follow-up.
Timepoint [1] 467522 0
3 months and 6 months postoperatively.
Secondary outcome [2] 467523 0
Pain interference at extended follow-up.
Timepoint [2] 467523 0
3 months and 6 months postoperatively.
Secondary outcome [3] 468026 0
Pain severity at extended follow-up.
Timepoint [3] 468026 0
3 months and 6 months postoperatively.

Eligibility
Key inclusion criteria
Adults aged 18 years or over scheduled for elective unilateral or bilateral total hip or total knee arthroplasty; adequate hearing; sufficient English-language proficiency to complete study materials; able to sit or lie still with eyes closed for 40 minutes daily; access to a personal listening device and headphones.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Epilepsy or history of seizures; cardiac pacemaker; pregnancy; hearing impairment precluding use of the audio intervention; insufficient English to provide informed consent or complete questionnaires.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed. The allocation sequence was computer-generated in advance (Research Randomizer), and participants were assigned to the next position in the sequence in order of consent by the researcher, who held the sequence list.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a computer-generated sequence (Research Randomizer, version 4.0).
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
A target sample of 42 was set with reference to prior meditation trials reporting effects with approximately 30 participants, allowing for anticipated attrition. Analyses comprised paired-samples t-tests of within-group change (baseline to 14 days) in pain severity, pain interference, and anxiety; repeated-measures ANCOVA testing the Time × Condition interaction for pain outcomes controlling for baseline anxiety; and hierarchical multiple regressions predicting postoperative pain and anxiety from gender, operation type, personality (mini-IPIP), and coping (Brief COPE). Bootstrapped (BCa) confidence intervals were used; alpha = .05 with Bonferroni adjustment where appropriate.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 322833 0
Commercial sector/Industry
Name [1] 322833 0
iAwake Technologies, LLC
Country [1] 322833 0
United States of America
Funding source category [2] 323026 0
University
Name [2] 323026 0
Bond University
Country [2] 323026 0
Australia
Primary sponsor type
University
Name
Bond University
Address
Country
Australia
Secondary sponsor category [1] 325874 0
None
Name [1] 325874 0
Address [1] 325874 0
Country [1] 325874 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321269 0
Bond University Human Research Ethics Committee
Ethics committee address [1] 321269 0
Ethics committee country [1] 321269 0
Australia
Date submitted for ethics approval [1] 321269 0
16/07/2018
Approval date [1] 321269 0
09/08/2018
Ethics approval number [1] 321269 0
Ethics committee name [2] 321364 0
Metro South Human Research Ethics Committee
Ethics committee address [2] 321364 0
Ethics committee country [2] 321364 0
Australia
Date submitted for ethics approval [2] 321364 0
15/11/2018
Approval date [2] 321364 0
07/02/2019
Ethics approval number [2] 321364 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153202 0
Prof Peta Stapleton
Address 153202 0
Bond University, 14 University Drive, Robina QLD 4226
Country 153202 0
Australia
Phone 153202 0
+61 7 5595 2515
Fax 153202 0
Email 153202 0
Contact person for public queries
Name 153203 0
Danielle Raynor
Address 153203 0
Bond University, 14 University Drive, Robina QLD 4226
Country 153203 0
Australia
Phone 153203 0
+61 417773467
Fax 153203 0
Email 153203 0
Contact person for scientific queries
Name 153204 0
Danielle Raynor
Address 153204 0
Bond University, 14 University Drive, Robina QLD 4226
Country 153204 0
Australia
Phone 153204 0
+61 417773467
Fax 153204 0
Email 153204 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Individual participant data will not be shared. Participant consent obtained in 2019 did not extend to public sharing of individual-level data, and the small single-region sample (N = 45 analysed) carries a material re-identification risk even after de-identification.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Basic resultsNo ACTRN12626001177347 Results.docx

Documents added automatically
No additional documents have been identified.